| Announce Date | 11/13/2025 |
| EPS Normalized Actual | $0.2288 (Beat by $7.4288) |
| EPS GAAP Actual | $0.2288 (Beat by $7.4288) |
| Revenue Actual | $0.000302506B |
| Revenue Surprise | Beat by $0.302506M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.1795 |
| EPS GAAP Estimate | $-0.1795 |
| Revenue Estimate | $0.0037466B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 1.4 | 5.4 | 0.92258 | 1.87742 | 1 |
| Dec 2028 | 0.685 | 11.04 | 0.43571 | 1.01155 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.26 | 0.51645 | 0.000302506B | 99.46% | -1.81M |
| FQ2 2025 (Jun 2025) | -2.5 | -2.1171 | 0B | -INF% | -2.42M |
| FQ1 2025 (Mar 2025) | -1.59 | -1.2219 | 1.472E-5B | 66.08% | -2M |
| FQ4 2024 (Dec 2024) | 0 | 0.1975 | 2.8093E-5B | 90.78% | -1.07M |
| FQ3 2024 (Sep 2024) | 0 | 0.21 | 1.625E-6B | 26.28% | -0.76M |
| FQ2 2024 (Jun 2024) | -0.21 | -1.55259 | 2.2625E-5B | 100% | 0.02M |
| FQ1 2024 (Mar 2024) | -0.23 | -0.23 | 4.993E-6B | 100% | 0M |
| FQ4 2023 (Dec 2023) | -0.18 | -0.18 | 2.589E-6B | 100% | 0M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.1795
Consensus Revenue Estimates
0.0037466B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | -0.0746 | -- | -0.12682 | -0.03085727 | 0 |
| FQ3 2026 (Sep 2026) | -0.1071 | 342.76 | -0.18207 | -0.04430045 | 0 |
| FQ2 2026 (Jun 2026) | -0.122 | -1949.18 | -0.2074 | -0.05046364 | 0 |
| FQ1 2026 (Mar 2026) | -0.1795 | -785.79 | -0.30515 | -0.07424773 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.01B | -- | 0.01B | 0.02B | 1 |
| FQ3 2026 (Sep 2026) | 0.01B | 95.64 | 0B | 0.01B | 1 |
| FQ2 2026 (Jun 2026) | 0.01B | -- | 0B | 0.01B | 1 |
| FQ1 2026 (Mar 2026) | 0B | 99.61 | 0B | 0.01B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
3
Revenue # of Misses
5
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.25645 | 0.26 | 0.51645 | 198.63% |
| FQ2 2025 (Jun 2025) | -0.3829 | -2.5 | -2.1171 | 84.68% |
| FQ1 2025 (Mar 2025) | -0.3681 | -1.59 | -1.2219 | 76.85% |
| FQ4 2024 (Dec 2024) | -0.1975 | 0 | 0.1975 | INF% |
| FQ3 2024 (Sep 2024) | -0.21 | 0 | 0.21 | INF% |
| FQ2 2024 (Jun 2024) | 1.34259 | -0.21 | -1.55259 | 739.33% |
| FQ1 2024 (Mar 2024) | -0.23 | -0.23 | 100% | |
| FQ4 2023 (Dec 2023) | -0.18 | -0.18 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0B | $-1.81M | -598% |
| FQ2 2025 (Jun 2025) | $0B | $0B | $-2.42M | -INF% |
| FQ1 2025 (Mar 2025) | $0B | $0B | $-2M | -13573.91% |
| FQ4 2024 (Dec 2024) | $0B | $0B | $-1.07M | -3815.57% |
| FQ3 2024 (Sep 2024) | $0B | $0B | $-0.76M | -46823.08% |
| FQ2 2024 (Jun 2024) | $0B | $0B | $0.02M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0B | $0M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0B | $0M | 100% |